Variant report
Variant | esv3386423 |
---|---|
Chromosome Location | chr3:47244248-47250946 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:47244351..47246647-chr3:47288782..47291421,2 | K562 | blood: | |
2 | chr3:47215840..47217709-chr3:47242966..47244606,2 | K562 | blood: | |
3 | chr3:47246768..47248949-chr3:47249706..47251385,2 | K562 | blood: | |
4 | chr3:47246768..47248949-chr3:47249706..47251385,2 | K562 | blood: | |
5 | chr3:47244578..47247467-chr3:47322927..47324918,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NBEAL2-2 | chr3:47248261-47248357 | refGeneNc_4033_NR_033373 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000114648 | chromatin interactions |
ENSG00000088727 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532630232 | chr3:47244338-47244339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527920115 | chr3:47244343-47244344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs151284515 | chr3:47244346-47244347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559919063 | chr3:47244392-47244393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374468691 | chr3:47244448-47244449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140487712 | chr3:47244457-47244458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567210156 | chr3:47244466-47244467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189738865 | chr3:47244470-47244471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549750365 | chr3:47244474-47244475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571114297 | chr3:47244490-47244491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372230917 | chr3:47244515-47244516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538726906 | chr3:47244543-47244544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553872873 | chr3:47244555-47244556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567006887 | chr3:47244564-47244565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs180817353 | chr3:47244572-47244573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185266428 | chr3:47244587-47244588 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs371738567 | chr3:47244632-47244633 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs150408720 | chr3:47244654-47244655 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs138123494 | chr3:47244669-47244670 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs565291168 | chr3:47244676-47244677 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs564815902 | chr3:47244681-47244682 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs11130120 | chr3:47244731-47244732 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs11130121 | chr3:47244740-47244741 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs577117495 | chr3:47244773-47244774 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs13063250 | chr3:47244820-47244821 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs535660763 | chr3:47244850-47244851 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs71098463 | chr3:47244941-47244942 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs13085911 | chr3:47244946-47244947 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs13085924 | chr3:47244964-47244965 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs199848251 | chr3:47244978-47244979 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs527519184 | chr3:47245021-47245022 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs548748581 | chr3:47245057-47245058 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs561077155 | chr3:47245099-47245100 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs112523765 | chr3:47245143-47245144 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs188181051 | chr3:47245147-47245148 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs549760297 | chr3:47245164-47245165 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs571242161 | chr3:47245190-47245191 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs368376829 | chr3:47245200-47245201 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs547549119 | chr3:47245236-47245237 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs565758469 | chr3:47245265-47245266 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs536894304 | chr3:47245289-47245290 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs555191752 | chr3:47245296-47245297 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs576521288 | chr3:47245303-47245304 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs181722869 | chr3:47245320-47245321 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs558959414 | chr3:47245366-47245367 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs111909757 | chr3:47245367-47245368 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs139015732 | chr3:47245487-47245488 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs553080342 | chr3:47245501-47245502 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs529390035 | chr3:47245538-47245539 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs574592720 | chr3:47245636-47245637 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Biliary cancer | 19435499 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Gastric cancer | 16891809 | CNVD |
Night blindness | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 17297452 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Melanoma | 17363583 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:47207000-47253800 | Weak transcription | Aorta | Aorta |
2 | chr3:47208000-47249600 | Weak transcription | Ovary | ovary |
3 | chr3:47208200-47256400 | Weak transcription | Brain Cingulate Gyrus | brain |
4 | chr3:47208200-47276600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr3:47221000-47250200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr3:47222800-47249000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
7 | chr3:47222800-47249400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr3:47223400-47245200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr3:47223400-47256600 | Weak transcription | Brain Inferior Temporal Lobe | brain |
10 | chr3:47223800-47252600 | Weak transcription | Fetal Muscle Leg | muscle |
11 | chr3:47223800-47269200 | Weak transcription | Fetal Muscle Trunk | muscle |
12 | chr3:47224200-47250200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr3:47236200-47256800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr3:47236800-47248400 | Weak transcription | Brain Angular Gyrus | brain |
15 | chr3:47238400-47256400 | Weak transcription | Right Atrium | heart |
16 | chr3:47245000-47247000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
17 | chr3:47245200-47245600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr3:47245400-47266600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
19 | chr3:47247000-47247400 | Strong transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
20 | chr3:47247000-47269400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr3:47247400-47249600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |